Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10–45.

PubMed  PubMed Central  Google Scholar 

Hernández-Silva CD, de Ramírez Arellano A, Pereira-Suárez AL, Ramírez-López IG. HPV and cervical cancer: molecular and immunological aspects, epidemiology and effect of vaccination in Latin American women. Viruses. 2024. https://doi.org/10.3390/v16030327.

Article  PubMed  PubMed Central  Google Scholar 

Mayadev JS, Ke G, Mahantshetty U, Pereira MD, Tarnawski R, Toita T. Global challenges of radiotherapy for the treatment of locally advanced cervical cancer. Int J Gynecol Cancer. 2022;32(3):436–45.

Article  PubMed  PubMed Central  Google Scholar 

Poddar P, Maheshwari A. Surgery for cervical cancer: consensus & controversies. Indian J Med Res. 2021;154(2):284–92. https://doi.org/10.4103/ijmr.IJMR_4240_20.

Article  PubMed  PubMed Central  Google Scholar 

Khan S, Gerber DE. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: a review. Semin Cancer Biol. 2020;64:93-101.

Article  PubMed  Google Scholar 

Yousuf S, Qiu M, von Voith Voithenberg L, Hulkkonen J, Macinkovic I, Schulz AR, et al. Spatially resolved multi-omics single-cell analyses inform mechanisms of immune dysfunction in pancreatic cancer. Gastroenterology. 2023;165(4):891-908.e14.

Article  CAS  PubMed  Google Scholar 

Gutiérrez-Hoya A, Soto-Cruz I. NK cell regulation in cervical cancer and strategies for immunotherapy. Cells. 2021. https://doi.org/10.3390/cells10113104.

Article  PubMed  PubMed Central  Google Scholar 

Fan J, Lu F, Qin T, Peng W, Zhuang X, Li Y, et al. Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance. Nat Genet. 2023;55(12):2175–88.

Article  CAS  PubMed  Google Scholar 

Yan H, Bu P. Non-coding RNA in cancer. Essays Biochem. 2021;65(4):625–39. https://doi.org/10.1042/EBC20200032.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Xiong C, Wei X, Yang H, Zhao C. Modeling ncRNA synergistic regulation in cancer. Methods Mol Biol. 2025;2883:377-402.

PubMed  Google Scholar 

Grammatikakis I, Lal A. Significance of lncRNA abundance to function. Mamm Genome. 2022;33(2):271–80.

Article  CAS  PubMed  Google Scholar 

Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun. 2021;41(2):109–20.

Article  Google Scholar 

Liu PW, Liu ZY, Deng SJ, Zhang X, Wang ZB, Wu NY, et al. A pyroptosis-related LncRNA signature for predicting prognosis, immune features and drug sensitivity in ovarian cancer. Onco Targets Ther. 2025;18:585–601.

Article  PubMed  PubMed Central  Google Scholar 

Xia Z, Wu J, Li Y, Yuan X, Sun J, Lv C, et al. LncRNA TYMSOS is a novel prognostic biomarker associated with immune infiltration in prostate cancer. Am J Cancer Res. 2023;13(10):4531–46.

CAS  PubMed  PubMed Central  Google Scholar 

Entezari M, Taheriazam A, Orouei S, Fallah S, Sanaei A, Hejazi ES, et al. LncRNA-miRNA axis in tumor progression and therapy response: an emphasis on molecular interactions and therapeutic interventions. Biomed Pharmacother. 2022;154:113609.

Article  CAS  PubMed  Google Scholar 

Yang L, Li LP, Yi HC. DeepWalk based method to predict lncRNA-miRNA associations via lncRNA-miRNA-disease-protein-drug graph. BMC Bioinform. 2022;22(Suppl 12):621.

Article  CAS  Google Scholar 

Shen T, Wang W, Wang H, Zhu X, Zhu G. Mitochondrial miRNA miR-134-5p play oncogenic role in clear cell renal cell carcinoma. Biomolecules. 2025. https://doi.org/10.3390/biom15030445.

Article  PubMed  PubMed Central  Google Scholar 

Yan L, Zhou R, Feng Y, Li R, Zhang L, Pan Y, et al. MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1/MMP2/PI3K/Akt pathway. Cell Death Discov. 2024;10(1):193.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang WY, Liu YJ, He Y, Chen P. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer. J Cell Physiol. 2019;234(4):4302–13.

Article  CAS  PubMed  Google Scholar 

Wang J, Lupo KB, Chambers AM, Matosevic S. Purinergic targeting enhances immunotherapy of CD73(+) solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells. J Immunother Cancer. 2018;6(1):136.

Article  PubMed  PubMed Central  Google Scholar 

Fang P, Xiang L, Chen W, Li S, Huang S, Li J, et al. LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3. Innate Immun. 2019;25(2):99–109.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia J, Liu Y, Yang X, Wu Z, Xu X, Kang F, et al. IncRNA TYMSOS promotes epithelial-mesenchymal transition and metastasis in thyroid carcinoma through regulating MARCKSL1 and activating the PI3K/Akt signaling pathway. Crit Rev Eukaryot Gene Expr. 2022;33(1):1–14.

Article  PubMed  Google Scholar 

Zhang Z, Wang J, Zhang X, Ran B, Wen J, Zhang H. TYMSOS-miR-101-3p-NETO2 axis promotes osteosarcoma progression. Mol Cell Probes. 2023;67:101887.

Article  CAS  PubMed  Google Scholar 

Gu Y, Wan C, Zhou G, Zhu J, Shi Z, Zhuang Z. TYMSOS drives the proliferation, migration, and invasion of gastric cancer cells by regulating ZNF703 via sponging miR-4739. Cell Biol Int. 2021;45(8):1710–9.

Article  CAS  PubMed  Google Scholar 

Park EG, Pyo SJ, Cui Y, Yoon SH, Nam JW. Tumor immune microenvironment lncRNAs. Brief Bioinform. 2022;23(1):bbab504. https://doi.org/10.1093/bib/bbab504.

Article  PubMed  Google Scholar 

Zhang KJ, Tan XL, Guo L. LncRNA TYMSOS facilitates breast cancer metastasis and immune escape through downregulating ULBP3. iScience. 2023;26(9):107556.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang QM, Lian GY, Sheng SM, Xu J, Ye LL, Min C, et al. Exosomal lncRNA NEAT1 inhibits NK-cell activity to promote multiple myeloma cell immune escape via an EZH2/PBX1 axis. Mol Cancer Res. 2024;22(2):125–36. https://doi.org/10.1158/1541-7786.MCR-23-0282.

Article  CAS  PubMed  Google Scholar 

Chi J, Liu T, Shi C, Luo H, Wu Z, Xiong B, et al. Long non-coding RNA LUCAT1 promotes proliferation and invasion in gastric cancer by regulating miR-134-5p/YWHAZ axis. Biomed Pharmacother. 2019;118:109201.

Article  CAS  PubMed  Google Scholar 

Li P, Huang G. Long noncoding RNA LINC00858 promotes the progression of ovarian cancer via regulating the miR-134-5p/TRIM44 axis. J Recept Signal Transduct Res. 2022;42(4):382–9. https://doi.org/10.1080/10799893.2021.1968433.

Article  CAS  PubMed  Google Scholar 

Xi C, Ye NY, Wang YB. LncRNA LINC01278 accelerates colorectal cancer progression via miR-134-5p/KDM2A axis. Eur Rev Med Pharmacol Sci. 2020;24(20):10526–34.

CAS  PubMed  Google Scholar 

Singhal A, Li BT, O’Reilly EM. Targeting KRAS in cancer. Nat Med. 2024;30(4):969–83.

Article  CAS  PubMed  PubMed Central